---
title: CDMO Daily News — August 27, 2026
slug: daily-news-2026-08-27-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: August 27 CDMO daily: 4basebio Expands Genezen Partnership for GMP Synthetic DNA in Viral Vector Manufacturing; Artis BioSolutions Opens Genetic Medicines…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-08-27-cdmo
published_at: 2026-08-27T00:00:19.869Z
last_updated: 2026-08-27T00:02:18.736Z
---

### [4basebio](/companies/4basebio) Expands [Genezen](/companies/genezen) Partnership for GMP Synthetic DNA in Viral Vector Manufacturing
- [4basebio](/companies/4basebio) and [Genezen](/companies/genezen) expanded their collaboration to supply enzymatically produced hpDNA® across Research Use Only, High-Quality, and GMP grades for viral vector and cell/gene therapy applications.
- 4basebio's cell-free synthetic DNA manufacturing reduces bacterial contamination, cuts DNA mass requirements by ~30% in AAV production, and shortens timelines versus traditional plasmid methods.

**Operational Impact**

[Genezen](/companies/genezen)'s expanded access to [4basebio](/companies/4basebio)'s GMP hpDNA® reduces viral vector manufacturing cycle time and input costs, enabling faster clinical progression for cell and gene therapy developers using Genezen's platform.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/4basebio-expands-genezen-collaboration-for-synthetic-dna-in-cell-and-gene-therapy)*

---

### [Artis BioSolutions](/companies/artis-biosolutions) Opens Genetic Medicines Center of Excellence in Bilbao
- [Artis BioSolutions](/companies/artis-biosolutions) launched an integrated Genetic Medicines Center of Excellence in Bilbao, Spain, offering synthetic DNA, mRNA drug substance, LNP formulation, and GMP drug product manufacturing under one roof.
- The facility consolidates early development through commercialization capabilities, aiming to reduce technology transfer complexity and accelerate program timelines for genetic medicine partners.

**Operational Impact**

Artis's Bilbao center adds European GMP drug-product capacity for mRNA and LNP therapies, complementing its Boston site and offering CDMO directors a single-vendor platform spanning synthetic DNA through commercial manufacturing.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/artis-biosolutions-opens-genetic-medicines-center-of-excellence-in-spain)*

## References

1. [PharmaSource RSS — 4basebio Expands Genezen Partnership for GMP Synthetic DNA in Viral Vector Manufacturing](https://pharmasource.global/content/news/cdmo-news/4basebio-expands-genezen-collaboration-for-synthetic-dna-in-cell-and-gene-therapy)
2. [Contract Pharma Breaking News RSS — Artis BioSolutions Opens Genetic Medicines Center of Excellence in Bilbao](https://www.contractpharma.com/breaking-news/artis-biosolutions-opens-genetic-medicines-center-of-excellence-in-spain)

Source: https://www.cdmo.directory/posts/daily-news-2026-08-27-cdmo